Overview

A Health Economic Trial in Adult Patients Undergoing Open Colectomy MA402S23B301

Status:
Terminated
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
This study is designed to compare the standard of care against EXPAREL (bupivacaine liposome extended-release injectable suspension) to determine if total opioid consumption is reduced when using EXPAREL therefore possibly reducing total hospitalization costs.
Phase:
Phase 4
Details
Lead Sponsor:
Pacira Pharmaceuticals, Inc
Collaborator:
Registrat-Mapi
Treatments:
Bupivacaine
Morphine